Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Postprandial glucose and healthcare resource use: a cross-sectional survey of adults with diabetes treated with basal-bolus insulin.

Pfeiffer KM, Sandberg A, Nikolajsen A, Brod M.

J Med Econ. 2018 Jan;21(1):66-73. doi: 10.1080/13696998.2017.1377208. Epub 2017 Sep 26.

PMID:
28875766
2.

Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.

Willis WD, Diago-Cabezudo JI, Madec-Hily A, Aslam A.

Expert Rev Pharmacoecon Outcomes Res. 2013 Feb;13(1):123-30. doi: 10.1586/erp.12.80.

PMID:
23402452
3.

Control of postprandial glucose levels with insulin in type 2 diabetes.

Blevins T.

Postgrad Med. 2011 Jul;123(4):135-47. doi: 10.3810/pgm.2011.07.2313. Review.

PMID:
21680998
4.

Relationship between glycemic control and diabetes-related hospital costs in patients with type 1 or type 2 diabetes mellitus.

Menzin J, Korn JR, Cohen J, Lobo F, Zhang B, Friedman M, Neumann PJ.

J Manag Care Pharm. 2010 May;16(4):264-75.

5.

Optimizing postprandial glycemia in pediatric patients with type 1 diabetes using insulin pump therapy: impact of glycemic index and prandial bolus type.

O'Connell MA, Gilbertson HR, Donath SM, Cameron FJ.

Diabetes Care. 2008 Aug;31(8):1491-5. doi: 10.2337/dc08-0306. Epub 2008 May 28.

6.

The association between use of mealtime insulin pens versus vials and healthcare charges and resource utilization in patients with type 2 diabetes: a retrospective cohort study.

Eby EL, Boye KS, Lage MJ.

J Med Econ. 2013 Oct;16(10):1231-7. doi: 10.3111/13696998.2013.823091. Epub 2013 Jul 23.

PMID:
23834480
8.

Contribution of fasting and postprandial hyperglycemia to hemoglobin A1c in insulin-treated Japanese diabetic patients.

Shimizu H, Uehara Y, Okada S, Mori M.

Endocr J. 2008 Aug;55(4):753-6. Epub 2008 May 23.

9.

Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.

Bonora E.

Int J Clin Pract Suppl. 2002 Jul;(129):5-11. Review.

PMID:
12166607
10.

The additional dose of insulin for high-protein mixed meal provides better glycemic control in children with type 1 diabetes on insulin pumps: randomized cross-over study.

Piechowiak K, Dżygało K, Szypowska A.

Pediatr Diabetes. 2017 Dec;18(8):861-868. doi: 10.1111/pedi.12500. Epub 2017 Jan 24.

PMID:
28117542
11.

Frequency of blood glucose testing among insulin-treated diabetes mellitus patients in the United Kingdom.

Lee WC, Smith E, Chubb B, Wolden ML.

J Med Econ. 2014 Mar;17(3):167-75. doi: 10.3111/13696998.2013.873722. Epub 2014 Feb 3.

PMID:
24359593
12.

Postprandial glucose regulation: new data and new implications.

Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, Owens DR, Tajima N, Tuomilehto J; International Prandial Glucose Regulation Study Group.

Clin Ther. 2005;27 Suppl B:S42-56. Review.

PMID:
16519037
13.

The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes.

Su JB, Yang XH, Zhang XL, Cai HL, Huang HY, Zhao LH, Xu F, Chen T, Cheng XB, Wang XQ, Lu Y.

PLoS One. 2017 Aug 28;12(8):e0183055. doi: 10.1371/journal.pone.0183055. eCollection 2017.

15.
16.

Improved Postprandial Glycemic Control with Faster-Acting Insulin Aspart in Patients with Type 1 Diabetes Using Continuous Subcutaneous Insulin Infusion.

Bode BW, Johnson JA, Hyveled L, Tamer SC, Demissie M.

Diabetes Technol Ther. 2017 Jan;19(1):25-33. doi: 10.1089/dia.2016.0350. Epub 2017 Jan 5.

17.

Impact and duration effect of telemonitoring on ΗbA1c, BMI and cost in insulin-treated Diabetes Mellitus patients with inadequate glycemic control: A randomized controlled study.

Fountoulakis S, Papanastasiou L, Gryparis A, Markou A, Piaditis G.

Hormones (Athens). 2015 Oct-Dec;14(4):632-43. doi: 10.14310/horm.2002.1603.

18.

Adding fast-acting insulin aspart to basal insulin significantly improved glycaemic control in patients with type 2 diabetes: A randomized, 18-week, open-label, phase 3 trial (onset 3).

Rodbard HW, Tripathy D, Vidrio Velázquez M, Demissie M, Tamer SC, Piletič M.

Diabetes Obes Metab. 2017 Oct;19(10):1389-1396. doi: 10.1111/dom.12955. Epub 2017 Jul 6.

19.

Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and wellbeing in insulin-treated patients with diabetes in seven European countries.

Geelhoed-Duijvestijn PH, Pedersen-Bjergaard U, Weitgasser R, Lahtela J, Jensen MM, Östenson CG.

J Med Econ. 2013 Dec;16(12):1453-61. doi: 10.3111/13696998.2013.852098. Epub 2013 Oct 25.

PMID:
24144009
20.

Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.

Yacoub T.

Postgrad Med. 2017 Nov;129(8):791-800. doi: 10.1080/00325481.2017.1389601. Epub 2017 Oct 14. Review.

PMID:
29032696

Supplemental Content

Support Center